CASI Pharmaceuticals (CASI) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

CASI Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$33.88M

Latest Revenue (Q)

$3.41M

Main Segment (Y)

E V O M E L A

Main Geography (Y)

E V O M E L A

CASI Pharmaceuticals Revenue by Period

CASI Pharmaceuticals Revenue by Year

Date	Revenue	Change
2023-12-31	$33.88M	-21.41%
2022-12-31	$43.11M	42.89%
2021-12-31	$30.17M	99.25%
2020-12-31	$15.14M	266.52%
2019-12-31	$4.13M	100.00%
2018-12-31	-	100.00%
2017-12-31	-	100.00%
2016-12-31	-	-100.00%
2015-12-31	$47.71K	101.09%
2014-12-31	$23.73K	100.00%
2013-12-31	-	-100.00%
2012-12-31	$669.31K	-65.52%
2011-12-31	$1.94M	-47.45%
2010-12-31	$3.69M	-30.11%
2009-12-31	$5.28M	-29.33%
2008-12-31	$7.48M	1.10%
2007-12-31	$7.40M	7.27%
2006-12-31	$6.89M	16.50%
2005-12-31	$5.92M	1051.38%
2004-12-31	$514.00K	-67.38%
2003-12-31	$1.58M	33.92%
2002-12-31	$1.18M	-36.81%
2001-12-31	$1.86M	-49.29%
2000-12-31	$3.67M	-26.56%
1999-12-31	$5.00M	-3.85%
1998-12-31	$5.20M	8.33%
1997-12-31	$4.80M	9.09%
1996-12-31	$4.40M	511.11%
1995-12-31	$720.00K	700.00%
1994-12-31	$90.00K	100.00%
1993-12-31	-	-

CASI Pharmaceuticals generated $33.88M in revenue during NA 2023, up -21.41% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

CASI Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2024-03-31	$3.41M	-44.03%
2023-12-31	$6.09M	-31.08%
2023-09-30	$8.84M	-10.00%
2023-06-30	$9.82M	17.65%
2023-03-31	$8.35M	-45.30%
2022-12-31	$15.26M	49.41%
2022-09-30	$10.21M	19.13%
2022-06-30	$8.57M	-5.40%
2022-03-31	$9.06M	-1.05%
2021-12-31	$9.16M	12.89%
2021-09-30	$8.11M	13.26%
2021-06-30	$7.16M	24.86%
2021-03-31	$5.74M	18.95%
2020-12-31	$4.82M	13.67%
2020-09-30	$4.24M	58.82%
2020-06-30	$2.67M	-21.58%
2020-03-31	$3.41M	153.42%
2019-12-31	$1.34M	-51.78%
2019-09-30	$2.79M	100.00%
2019-06-30	-	100.00%
2019-03-31	-	100.00%
2018-12-31	-	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	100.00%
2017-12-31	-	100.00%
2017-09-30	-	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	-100.00%
2015-12-31	$5.42K	100.00%
2015-09-30	-	-100.00%
2015-06-30	$23.99K	1.16%
2015-03-31	$23.72K	-0.04%
2014-12-31	$23.73K	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	-100.00%
2012-12-31	$669.31K	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	-100.00%
2011-12-31	$1.93M	100.00%
2011-09-30	-	-100.00%
2011-06-30	$8.85K	100.00%
2011-03-31	-	-100.00%
2010-12-31	$3.69M	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	-100.00%
2009-12-31	$1.62M	-55.95%
2009-09-30	$3.67M	100.00%
2009-06-30	-	100.00%
2009-03-31	-	-100.00%
2008-12-31	$3.98M	13.56%
2008-09-30	$3.50M	100.00%
2008-06-30	-	100.00%
2008-03-31	-	-100.00%
2007-12-31	$3.88M	-

CASI Pharmaceuticals generated $3.41M in revenue during Q1 2024, up -44.03% compared to the previous quarter, and up 22.34% compared to the same period a year ago.

CASI Pharmaceuticals Revenue Breakdown

CASI Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 19
E V O M E L A	$4.10M

CASI Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 19: E V O M E L A (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
E V O M E L A	$4.20M	$2.60M	$3.40M	$1.40M	$2.70M

CASI Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 20: E V O M E L A (100.00%).

CASI Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 19
E V O M E L A	$4.10M

CASI Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 19: E V O M E L A (100.00%).

Quarterly Revenue by Country

Country	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
E V O M E L A	$4.20M	$2.60M	$3.40M	$1.40M	$2.70M

CASI Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 20: E V O M E L A (100.00%).

CASI Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CDTX	Cidara Therapeutics	$63.91M	-
CASI	CASI Pharmaceuticals	$33.88M	$3.41M
CBIO	Gyre Therapeutics	$794.00K	-
VBLT	Notable Labs	$658.00K	-
CLRB	Cellectar Biosciences	-	-
CFRX	ContraFect	-	-

CASI Revenue FAQ

What is CASI Pharmaceuticals’s yearly revenue?

CASI Pharmaceuticals's yearly revenue for 2023 was $33.88M, representing a decrease of -21.41% compared to 2022. The company's yearly revenue for 2022 was $43.11M, representing an increase of 42.89% compared to 2021. CASI's yearly revenue for 2021 was $30.17M, representing an increase of 99.25% compared to 2020.

What is CASI Pharmaceuticals’s quarterly revenue?

CASI Pharmaceuticals's quarterly revenue for Q1 2024 was $3.41M, a -44.03% decrease from the previous quarter (Q4 2023), and a -59.16% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $6.09M, a -31.08% decrease from the previous quarter (Q3 2023), and a -60.08% decrease year-over-year (Q4 2022). CASI's quarterly revenue for Q3 2023 was $8.84M, a -10.00% decrease from the previous quarter (Q2 2023), and a -13.46% decrease year-over-year (Q3 2022).

What is CASI Pharmaceuticals’s revenue growth rate?

CASI Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 12.30%, and for the last 5 years (2019-2023) was 720.12%.

What are CASI Pharmaceuticals’s revenue streams?

CASI Pharmaceuticals's revenue streams in c 19 are E V O M E L A

What is CASI Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 19, the largest source of revenue of CASI Pharmaceuticals was E V O M E L A. This segment made a revenue of $4.1M, representing 100.00% of the company's total revenue.